Actinium

About Actinium

Actinium gave the actinide series its name, and in working chemistry it mostly shows up as a problem of supply. The Ac-227 isotope has a 21.8-year half-life and emits enough alpha and beta radiation to ionize the air around a sample, producing the pale blue glow that makes shielded ampoules photogenic. The more interesting isotope right now is Ac-225, which has a 9.9-day half-life and a decay chain that fires four alpha particles in quick succession. Couple it to a tumor-targeting antibody or a PSMA ligand and you get targeted alpha therapy — concentrated, short-range damage delivered cell-by-cell. The PSMA-617 trials in metastatic castration-resistant prostate cancer pushed Ac-225 into clinical headlines, and AML protocols have been chasing it for years. The bottleneck is brutal: most Ac-225 still comes from milking U-233 stockpiles at Oak Ridge, ITU Karlsruhe, and ROSATOM, with high-energy proton spallation routes at TRIUMF and BNL only now ramping. The chemistry of Ac3+ is essentially scaled-up lanthanum chemistry — same hard-Lewis-acid behavior, same DOTA-style chelators borrowed from gadolinium contrast work.